___

1. Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006; 58:389-462.

2. Lambert DM, Fowler CJ. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J Med Chem 2005; 48:5059-87.

3. Evren C, Bozkurt M. Sentetik kannabinoidler: Son yılların krizi. Düşünen Adam 2013; 26(1):1-11.

4. Hopkins CY, Gilchrist BLY. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids. J Emerg Med 2013;45(4):544-546.

5. Allen JH, De Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 2004; 53:1566-70.

6. Sontineni SP, Chaudhary S, Sontineni V, Lanspa SJ. Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse. World J Gastroenterol 2009; 15:1264-6.

7. Simonetto DA Oxentenko AS, et al. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc 2012; 87:114-9.